AstraZeneca withdraws U.S. application for COVID vaccine

AstraZeneca is no longer pursuing U.S. approval of its COVID-19 vaccine, Chief Executive Pascal Soriot said in a media call on Thursday.

Demand for vaccines in the country is declining and the market is well served by the mRNA shots, he said.